AREV Life Sciences Global Corp. (AREVF)

OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jan 29, 2026
-95.00%
Market Cap 15.88K
Revenue (ttm) 5.33K
Net Income (ttm) -177.08K
Shares Out 31.76M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 8,875
Open 0.0005
Previous Close 0.0005
Day's Range 0.0005 - 0.0005
52-Week Range 0.0005 - 0.0005
Beta 5.39
RSI 41.35
Earnings Date n/a

About AREV Life Sciences Global

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company’s pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient suppleme... [Read more]

Sector Healthcare
CEO Michael Withrow
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol AREVF
Full Company Profile

Financial Performance

In 2022, AREV Life Sciences Global's revenue was 49,113, a decrease of -80.74% compared to the previous year's 254,996. Losses were -1.44 million, 45.8% more than in 2021.

Financial numbers in CAD Financial Statements

News

There is no news available yet.